ADMA BIOLOGICS, INC. (ADMA) Annual Reports
ADMA BIOLOGICS, INC. is listed on Nasdaq, classified by the SEC under Biological Products, (No Diagnostic Substances) (SIC 2836). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.
Company profile
- Exchange： Nasdaq
- Fiscal year end： 12/31
- SEC CIK： 1368514 →
Website：Official site ↗
Financial Highlights
| Current | Prior year | YoY | |
|---|---|---|---|
| Revenue | $124.4M | $122.0M | +2.0% |
| Operating income | $52.4M | $42.8M | +22.5% |
| Net income | $37.8M | $34.2M | +10.5% |
| EPS (diluted) | $0.16 | $0.14 | +14.3% |
Source: SEC EDGAR (XBRL company facts)
Financial history
Revenue & profit
Quarterly · In mn (USD)
Revenue 124 mn
Net income 37.8 mn
Show table：Income statement
| Item | 2009Q4 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2011Q4 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q3 | 2020Q4 | 2020Q4 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0 | — | 0 | 0.76 | 0 | 0.23 | 0.36 | 0.52 | 0.79 | 0.74 | 1.11 | 0.42 | 1.54 | 1.50 | 1.37 | 1.49 | 1.50 | 1.31 | 1.85 | 2.51 | 2.12 | 2.27 | 2.94 | 3.33 | 2.63 | 3.40 | 4.73 | 12.0 | 4.04 | 4.66 | 4.23 | 4.06 | 3.53 | 6.56 | 7.22 | 12.0 | 10.2 | 7.79 | 10.3 | 14.0 | 16.1 | 17.8 | 20.7 | 26.4 | 29.1 | 33.9 | 41.1 | 50.0 | 56.9 | 60.1 | 67.3 | 73.9 | 81.9 | 107 | 120 | 118 | 115 | 122 | 134 | 139 | 114 | 124 |
| Gross profit | — | — | — | — | — | — | 0 | 0.55 | 0 | 0.09 | 0.22 | 0.14 | 0.26 | 0.26 | 0.38 | 0.14 | 0.58 | 0.56 | 0.5 | 0.53 | 0.59 | 0.52 | 0.74 | 1.01 | 0.86 | 0.93 | 1.20 | 1.31 | 1.01 | -0.93 | -6.56 | 0.08 | — | — | — | -25.2 | — | — | — | — | — | — | — | -19.1 | -1.72 | -1.00 | 0.39 | 3.51 | 3.66 | 7.77 | 9.66 | 14.2 | 16.5 | 16.7 | 24.6 | 31.1 | 39.1 | 57.5 | 59.7 | 63.3 | 61.1 | 67.2 | 75.6 | 88.8 | 80.8 | 86.3 |
| Operating income | — | — | — | — | -1.59 | -2.15 | -0.77 | -0.12 | -1.21 | -1.21 | -3.25 | -2.24 | -3.15 | -4.84 | -2.53 | -4.52 | -5.68 | -3.59 | -3.04 | -3.71 | -3.20 | -3.52 | -4.66 | -4.13 | -4.16 | -5.49 | -3.74 | -3.94 | -5.94 | -8.40 | -14.4 | -10.5 | -16.5 | -13.4 | -13.8 | -16.6 | -13.2 | -11.3 | -9.05 | -7.83 | -16.8 | -17.1 | -13.8 | -17.2 | -15.2 | -15.6 | -14.4 | -13.2 | -14.8 | -9.17 | -9.32 | -6.06 | -0.81 | -0.47 | 8.69 | 14.2 | 21.8 | 39.2 | 39.6 | 38.3 | 34.9 | 42.8 | 51.0 | 62.8 | 58.3 | 52.5 |
| Net income | -0.02 | -0.02 | 0 | -0.01 | -1.58 | -2.39 | -0.01 | -0.01 | -0.6 | -1.21 | -3.25 | -2.25 | -3.24 | -4.90 | -2.69 | -4.70 | -5.90 | -3.96 | -3.38 | -3.56 | -3.61 | -4.68 | -5.10 | -4.58 | -4.61 | -6.01 | -4.33 | -4.56 | -6.54 | -9.04 | -15.2 | -13.0 | -17.8 | -14.8 | -15.1 | -18.0 | -13.1 | -13.2 | -11.4 | -10.6 | -19.3 | -20.2 | -16.9 | -19.4 | -18.4 | -18.9 | -17.7 | -16.6 | -25.0 | -13.8 | -14.9 | -12.2 | -6.79 | -6.37 | 2.57 | -17.6 | 17.8 | 32.1 | 35.9 | 112 | 26.9 | 34.2 | 36.4 | 49.4 | 45.3 | 37.8 |
Balance sheet
Quarterly · In mn (USD)
Total assets 684 mn
Total liabilities 276 mn
Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.
Show table：Balance sheet
| Item | 2009Q4 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2011Q4 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q3 | 2020Q4 | 2020Q4 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | — | — | — | — | — | — | — | 1.29 | 15.8 | 14.6 | 12.0 | 13.9 | 12.3 | 9.17 | 7.14 | 31.1 | 30.8 | 26.5 | 22.6 | 24.1 | 31.0 | 27.1 | 25.2 | 21.3 | 17.4 | 29.5 | 25.4 | 21.7 | 15.7 | 44.3 | 31.4 | 63.2 | 46.4 | 73.6 | 62.5 | 44.5 | 38.3 | 104 | 97.3 | 85.8 | 165 | 143 | 140 | 154 | 177 | 171 | 175 | 209 | 240 | 223 | 224 | 270 | 264 | 266 | 274 | 257 | 276 | 304 | 318 | 331 | 352 | 400 | 403 | 467 | 511 | 528 |
| Total assets | — | — | — | — | — | 0.01 | 0.01 | 0.01 | 17.0 | 15.9 | 13.2 | 15.6 | 13.8 | 10.7 | 8.70 | 32.0 | 31.9 | 27.9 | 25.3 | 27.2 | 33.9 | 29.8 | 27.8 | 23.7 | 19.7 | 31.7 | 27.5 | 23.7 | 17.6 | 84.6 | 72.8 | 108 | 91.1 | 118 | 106 | 88.9 | 78.1 | 143 | 138 | 127 | 211 | 192 | 190 | 208 | 236 | 233 | 239 | 276 | 308 | 297 | 301 | 348 | 341 | 343 | 349 | 329 | 351 | 376 | 391 | 489 | 511 | 558 | 569 | 624 | 665 | 684 |
| Current liabilities | — | — | — | — | — | 0.01 | 0.01 | 0.01 | 1.03 | 1.01 | 1.40 | 1.82 | 2.10 | 2.03 | 2.52 | 3.66 | 4.30 | 3.80 | 4.12 | 4.20 | 3.79 | 3.20 | 4.30 | 4.22 | 4.29 | 5.08 | 9.21 | 11.2 | 13.0 | 15.7 | 13.3 | 9.44 | 9.44 | 6.92 | 9.89 | 9.63 | 8.34 | 10.1 | 15.2 | 14.0 | 13.9 | 12.9 | 16.5 | 19.9 | 21.2 | 18.2 | 32.3 | 30.4 | 31.6 | 28.1 | 44.4 | 39.3 | 36.7 | 42.0 | 41.8 | 49.8 | 53.1 | 44.2 | 44.9 | 55.5 | 53.5 | 74.9 | 56.5 | 69.5 | 73.5 | 75.8 |
| Total liabilities | — | — | — | — | — | — | — | 2.54 | 1.26 | 1.23 | 1.62 | 6.13 | 7.42 | 8.96 | 9.44 | 10.4 | 16.1 | 15.6 | 16.0 | 21.2 | 20.5 | 20.3 | 22.9 | 22.9 | 23.1 | 27.8 | 27.6 | 28.1 | 28.4 | 57.0 | 59.8 | 67.7 | 68.1 | 66.0 | 69.1 | 69.1 | 68.1 | 96.4 | 102 | 101 | 114 | 115 | 119 | 119 | 123 | 121 | 136 | 135 | 181 | 183 | 200 | 196 | 195 | 196 | 198 | 194 | 197 | 188 | 159 | 140 | 137 | 160 | 138 | 147 | 275 | 276 |
| Equity | 0 | 0 | — | -3.93 | — | 0 | 0 | 0 | 15.8 | 14.7 | 11.6 | 9.42 | 6.40 | 1.73 | -0.74 | 21.6 | 15.9 | 12.3 | 9.24 | 6.01 | 13.4 | 9.52 | 4.91 | 0.82 | -3.37 | 3.92 | -0.15 | -4.46 | -10.8 | 27.7 | 13.0 | 40.3 | 23.0 | 51.8 | 37.2 | 19.8 | 10.0 | 46.9 | 36.1 | 26.2 | 96.3 | 76.9 | 71.4 | 88.3 | 113 | 112 | 103 | 141 | 127 | 114 | 100 | 152 | 146 | 147 | 151 | 135 | 154 | 188 | 232 | 349 | 373 | 398 | 431 | 477 | 390 | 408 |
Cash flow
Quarterly · In mn (USD)
Operating 29.5 mn
Investing -2.26 mn
Financing -29.4 mn
Positive = cash in, negative = cash out.
Show table：Cash flow statement
| Item | 2009Q4 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2011Q4 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q3 | 2020Q4 | 2020Q4 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | — | -0.01 | -0.01 | -0.45 | -0.54 | -0.01 | -0.01 | -2.00 | -1.00 | -2.10 | -1.81 | -3.07 | -2.63 | -2.23 | -2.96 | -5.04 | -4.30 | -2.47 | -2.90 | -4.22 | -4.45 | -2.67 | -4.08 | -5.17 | -4.80 | -4.68 | -3.61 | -5.40 | -8.78 | -9.74 | -13.4 | -16.4 | -14.9 | -12.5 | -18.8 | -14.3 | -18.6 | -23.6 | -19.6 | -24.6 | -21.3 | -23.9 | -32.2 | -33.2 | -32.3 | -13.4 | -33.5 | -26.0 | -12.8 | -13.3 | -7.38 | -14.7 | -6.06 | 12.0 | 17.6 | -2.22 | 45.6 | 25.0 | 50.2 | -19.7 | 21.1 | 13.3 | 35.6 | 58.3 | 29.5 |
| Investing | — | — | — | — | 0 | — | 0 | 0 | 0 | -0.06 | -0.03 | -0.04 | -0.07 | -0.11 | -0.02 | -2.94 | 0.62 | -4.37 | -1.40 | 1.11 | -6.87 | -4.43 | 4.16 | 5.40 | 3.66 | -8.62 | 0.24 | 5.63 | 5.14 | 12.7 | -0.57 | -2.01 | -0.55 | -0.5 | -0.23 | -0.82 | -0.11 | -0.14 | -1.97 | -1.59 | -2.07 | -4.17 | -2.89 | -3.60 | -2.57 | -4.48 | -2.79 | -3.68 | -2.84 | -3.94 | -3.38 | -3.75 | -1.94 | -0.87 | -0.76 | -1.41 | -2.36 | -2.37 | -1.10 | -2.75 | -4.72 | -2.53 | -14.4 | -0.28 | 2.40 | -2.26 |
| Financing | — | — | — | 0.01 | 0.3 | 0.55 | 0 | 0.02 | 16.1 | -0.3 | -0.04 | 3.66 | 0.93 | 0.07 | -0.03 | 26.7 | 4.79 | 0.02 | -0.05 | 5.04 | 10.5 | 0.13 | -0.13 | -0.06 | 0 | 17.0 | -0.2 | 0 | -1.12 | 13.2 | -1.66 | 50.4 | 0 | 42.9 | -0.01 | 0 | 4.18 | 75.8 | -0.01 | -0.01 | 101 | 0 | 10.6 | 32.1 | 41.8 | 17.2 | 8.20 | 53.8 | 47.3 | -0.32 | -0.84 | 62.7 | -0.65 | 0.24 | 0.42 | -39.0 | -1.45 | -0.36 | -25.5 | -31.0 | -7.13 | 0.05 | -27.8 | -9.12 | -10.1 | -29.4 |
| Cash at period end | — | 0.01 | 0 | 0 | 0.08 | 0.01 | 0.01 | 0.01 | 14.2 | 12.9 | 10.7 | 12.5 | 10.3 | 7.65 | 5.38 | 26.1 | 26.5 | 17.9 | 13.9 | 17.2 | 16.6 | 7.82 | 9.18 | 10.4 | 8.93 | 12.6 | 7.91 | 9.91 | 8.54 | 25.6 | 13.6 | 43.1 | 26.1 | 55.1 | 42.4 | 22.8 | 16.5 | 73.6 | 48.0 | 26.8 | 101 | 75.8 | 59.7 | 55.9 | 62.0 | 42.4 | 34.4 | 51.1 | 69.5 | 52.4 | 34.9 | 86.5 | 69.2 | 62.5 | 74.2 | 51.4 | 45.3 | 88.2 | 86.7 | 103 | 71.6 | 90.3 | 61.4 | 87.6 | 138 | 136 |
Profitability
Quarterly · %
Gross margin 69.4%
Operating margin 42.2%
Net margin 30.4%
Gross, operating and net margin = the respective profit ÷ revenue.
Show table：Profitability
| Item | 2009Q4 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2011Q4 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q3 | 2020Q4 | 2020Q4 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | 72.7% | 50.0% | 38.3% | 59.9% | 27.3% | 33.3% | 34.6% | 34.4% | 33.4% | 37.9% | 37.3% | 36.5% | 35.7% | 39.5% | 40.0% | 39.9% | 40.2% | 40.4% | 40.8% | 40.9% | 39.5% | 38.5% | -27.5% | -138.7% | 0.7% | — | — | — | -621.5% | — | — | — | — | — | — | — | -136.7% | -10.7% | -5.6% | 1.9% | 13.3% | 12.6% | 22.9% | 23.5% | 28.4% | 29.0% | 27.8% | 36.6% | 42.1% | 47.8% | 53.6% | 49.8% | 53.9% | 53.2% | 55.1% | 56.3% | 63.8% | 70.5% | 69.4% |
| Operating margin | — | — | — | — | — | — | — | -16.0% | -27579.6% | -524.4% | -901.6% | -428.1% | -397.3% | -651.6% | -228.6% | -1065.5% | -368.7% | -239.1% | -222.4% | -249.1% | -213.1% | -268.5% | -251.8% | -164.4% | -195.8% | -241.7% | -127.2% | -118.5% | -225.8% | -247.2% | -305.1% | -87.8% | -409.0% | -288.1% | -326.0% | -407.9% | -374.3% | -172.8% | -125.3% | -65.0% | -164.4% | -219.9% | -134.3% | -123.4% | -94.5% | -87.4% | -69.8% | -50.0% | -50.9% | -27.1% | -22.7% | -12.1% | -1.4% | -0.8% | 12.9% | 19.3% | 26.6% | 36.6% | 33.1% | 32.6% | 30.4% | 35.1% | 38.0% | 45.1% | 50.9% | 42.2% |
| Net margin | — | — | — | — | — | — | — | -1.1% | -13575.3% | -524.4% | -900.8% | -430.3% | -408.8% | -658.6% | -242.8% | -1108.7% | -382.9% | -264.0% | -247.8% | -239.3% | -239.9% | -357.2% | -275.4% | -182.4% | -217.2% | -264.7% | -147.4% | -137.0% | -248.7% | -265.8% | -321.4% | -108.2% | -440.9% | -316.7% | -357.8% | -444.7% | -370.4% | -201.4% | -158.4% | -87.7% | -188.7% | -259.1% | -164.6% | -139.1% | -114.5% | -106.0% | -85.7% | -63.1% | -85.9% | -40.6% | -36.3% | -24.5% | -11.9% | -10.6% | 3.8% | -23.9% | 21.8% | 29.9% | 30.0% | 95.2% | 23.4% | 28.1% | 27.1% | 35.5% | 39.6% | 30.4% |
Returns & leverage
Quarterly · %
ROE 41.9%
ROA 27.2%
Debt ratio 40.3%
ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.
Show table：Returns & leverage
| Item | 2009Q4 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2011Q4 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q3 | 2020Q4 | 2020Q4 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | -19.0% | -24.8% | -87.2% | -154.9% | -89.8% | -166.4% | -240.6% | -100.2% | -163.1% | -246.0% | -421.9% | -121.9% | -99.0% | -139.6% | -239.4% | -526.2% | -377.2% | -302.3% | -820.6% | — | — | -154.8% | -550.4% | -243.9% | -897.4% | -153.0% | -241.8% | -218.8% | -368.9% | -120.5% | -152.1% | -210.1% | -102.4% | -99.2% | -124.5% | -132.4% | -71.7% | -78.1% | -85.5% | -62.5% | -65.4% | -64.7% | -69.2% | -45.0% | -35.0% | -30.9% | -18.1% | -19.7% | -2.4% | 20.8% | 35.5% | 81.7% | 78.5% | 71.2% | 63.2% | 35.6% | 43.3% | 41.9% |
| ROA | — | — | — | — | — | -46727.8% | -67321.0% | -49277.1% | -17.6% | -22.9% | -76.5% | -93.8% | -64.5% | -102.6% | -119.3% | -65.3% | -79.5% | -89.5% | -105.6% | -56.8% | -44.1% | -52.8% | -63.8% | -70.5% | -70.8% | -66.0% | -70.6% | -82.3% | -115.0% | -42.0% | -70.5% | -66.5% | -101.3% | -60.0% | -67.8% | -66.8% | -72.1% | -45.5% | -45.7% | -44.7% | -37.7% | -36.7% | -40.8% | -45.3% | -33.6% | -34.7% | -34.7% | -29.6% | -28.8% | -27.6% | -26.1% | -21.1% | -14.7% | -12.6% | -7.0% | -8.3% | -1.1% | 9.7% | 18.4% | 48.3% | 48.0% | 44.7% | 43.7% | 26.4% | 28.1% | 27.2% |
| Debt ratio | — | — | — | — | — | — | — | 31440.7% | 7.4% | 7.7% | 12.2% | 39.4% | 53.7% | 83.8% | 108.5% | 32.5% | 50.2% | 55.9% | 63.4% | 77.9% | 60.4% | 68.1% | 82.3% | 96.5% | 117.1% | 87.7% | 100.5% | 118.8% | 161.1% | 67.3% | 82.2% | 62.7% | 74.7% | 56.0% | 65.0% | 77.8% | 87.2% | 67.3% | 73.8% | 79.4% | 54.2% | 59.9% | 62.4% | 57.5% | 52.3% | 52.1% | 56.9% | 48.9% | 58.8% | 61.5% | 66.6% | 56.4% | 57.3% | 57.2% | 56.6% | 58.9% | 56.2% | 50.0% | 40.6% | 28.6% | 26.9% | 28.7% | 24.2% | 23.5% | 41.3% | 40.3% |
EPS
Quarterly · US$
EPS US$0.16
Show table：EPS
| Item | 2009Q4 | 2010Q4 | 2011Q1 | 2011Q2 | 2011Q3 | 2011Q4 | 2011Q4 | 2011Q4 | 2012Q1 | 2012Q2 | 2012Q3 | 2012Q4 | 2013Q1 | 2013Q2 | 2013Q3 | 2013Q4 | 2014Q1 | 2014Q2 | 2014Q3 | 2014Q4 | 2015Q1 | 2015Q2 | 2015Q3 | 2015Q4 | 2016Q1 | 2016Q2 | 2016Q3 | 2016Q4 | 2017Q1 | 2017Q2 | 2017Q3 | 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q3 | 2020Q4 | 2020Q4 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS（US$） | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -0.23 | -0.19 | -0.20 | -0.16 | -0.15 | -0.13 | -0.07 | -0.13 | -0.07 | -0.08 | -0.06 | -0.03 | -0.03 | 0.01 | -0.08 | 0.08 | 0.13 | 0.15 | 0.46 | 0.11 | 0.14 | 0.15 | 0.20 | 0.19 | 0.16 |
Revenue & profit
Year-to-date · In mn (USD)
Revenue 239 mn
Net income 83.2 mn
Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.
Balance sheet
Year-to-date · In mn (USD)
Total assets 684 mn
Total liabilities 276 mn
Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.
Cash flow
Year-to-date · In mn (USD)
Operating 87.8 mn
Investing 0.15 mn
Financing -39.5 mn
Positive = cash in, negative = cash out.
Profitability
Year-to-date · %
Gross margin 69.9%
Operating margin 46.4%
Net margin 34.8%
Gross, operating and net margin = the respective profit ÷ revenue.
Returns & leverage
Year-to-date · %
ROE 41.9%
ROA 27.2%
Debt ratio 40.3%
ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.
EPS
Year-to-date · US$
EPS US$0.35
Revenue & profit
Annual · In mn (USD)
Revenue 510 mn
Net income 147 mn
Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.
Show table：Income statement
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.12 | 3.07 | 5.90 | 7.18 | 10.7 | 22.8 | 17.0 | 29.4 | 80.9 | 154 | 258 | 426 | 510 |
| Gross profit | — | 0.45 | 1.04 | 2.17 | 2.87 | 4.30 | -6.40 | — | — | 1.17 | 35.3 | 88.9 | 220 | 293 |
| Operating income | — | -7.91 | -15.0 | -16.0 | -15.5 | -17.3 | -39.3 | -60.3 | -41.4 | -58.4 | -39.4 | 21.6 | 139 | 191 |
| Net income | -3.99 | -7.30 | -15.5 | -16.8 | -18.0 | -19.5 | -43.8 | -65.7 | -48.3 | -71.7 | -65.9 | -28.2 | 198 | 147 |
Balance sheet
Annual · In mn (USD)
Total assets 624 mn
Total liabilities 147 mn
Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.
Show table：Balance sheet
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | — | 13.9 | 31.1 | 24.1 | 21.3 | 21.7 | 63.2 | 44.5 | 85.8 | 209 | 270 | 257 | 331 | 467 |
| Total assets | 0.01 | 15.6 | 32.0 | 27.2 | 23.7 | 23.7 | 108 | 88.9 | 127 | 276 | 348 | 329 | 489 | 624 |
| Current liabilities | 0.01 | 1.82 | 3.66 | 4.20 | 4.22 | 11.2 | 9.44 | 9.63 | 14.0 | 30.4 | 39.3 | 49.8 | 55.5 | 69.5 |
| Total liabilities | — | 6.13 | 10.4 | 21.2 | 22.9 | 28.1 | 67.7 | 69.1 | 101 | 135 | 196 | 194 | 140 | 147 |
| Equity | 0 | 9.42 | 21.6 | 6.01 | 0.82 | -4.46 | 40.3 | 19.8 | 26.2 | 141 | 152 | 135 | 349 | 477 |
Cash flow
Annual · In mn (USD)
Operating 50.4 mn
Investing -21.9 mn
Financing -44.0 mn
Positive = cash in, negative = cash out.
Show table：Cash flow statement
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -1.02 | -6.90 | -10.9 | -14.7 | -15.4 | -18.3 | -37.3 | -62.7 | -76.2 | -112 | -59.5 | 8.80 | 119 | 50.4 |
| Investing | — | -0.12 | -3.13 | -4.04 | -1.74 | 0.9 | 15.2 | -2.10 | -3.81 | -13.5 | -13.9 | -4.98 | -8.57 | -21.9 |
| Financing | — | 19.5 | 27.6 | 9.80 | 10.4 | 16.8 | 60.8 | 42.9 | 80.0 | 121 | 109 | -39.0 | -58.3 | -44.0 |
| Cash at period end | 0.01 | 12.5 | 26.1 | 17.2 | 10.4 | 9.91 | 43.1 | 22.8 | 26.8 | 51.1 | 86.5 | 51.4 | 103 | 87.6 |
Profitability
Annual · %
Gross margin 57.4%
Operating margin 37.5%
Net margin 28.8%
Gross, operating and net margin = the respective profit ÷ revenue.
Show table：Profitability
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 40.2% | 34.0% | 36.9% | 39.9% | 40.3% | -28.1% | — | — | 1.4% | 22.9% | 34.4% | 51.5% | 57.4% |
| Operating margin | — | -707.4% | -490.4% | -271.6% | -216.1% | -162.6% | -172.7% | -354.9% | -141.1% | -72.1% | -25.6% | 8.4% | 32.6% | 37.5% |
| Net margin | — | -653.0% | -506.2% | -285.1% | -250.4% | -183.1% | -192.3% | -387.1% | -164.5% | -88.5% | -42.8% | -10.9% | 46.4% | 28.8% |
Returns & leverage
Annual · %
ROE 35.6%
ROA 26.4%
Debt ratio 23.5%
ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.
Show table：Returns & leverage
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | -155.0% | -100.2% | -121.9% | -526.2% | — | -243.9% | -218.8% | -210.1% | -85.6% | -45.0% | -19.7% | 81.7% | 35.6% |
| ROA | -46886.4% | -93.8% | -65.3% | -56.8% | -70.5% | -82.3% | -66.5% | -66.8% | -44.7% | -35.5% | -21.1% | -8.3% | 48.3% | 26.4% |
| Debt ratio | — | 39.4% | 32.5% | 77.9% | 96.5% | 118.8% | 62.7% | 77.8% | 79.4% | 48.9% | 56.4% | 58.9% | 28.6% | 23.5% |
EPS
Annual · US$
EPS US$0.60
Show table：EPS
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS（US$） | — | — | — | — | — | — | — | — | — | -0.51 | -0.34 | -0.13 | 0.82 | 0.60 |
Source: SEC EDGAR (XBRL company facts)
Annual reports by year
| 10-K | |
|---|---|
| 2025 | Open full text → |
| 2024 | Open full text → |
| 2023 | Open full text → |
10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.
FAQ
Where can I read ADMA BIOLOGICS, INC. (ADMA) annual reports?
Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.
What is the difference between a 10-K and a 20-F?
A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.
Are earnings call materials available here?
No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.
Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.
Back to US annual reports, or see the supply-chain maps.